Tests:Carcinoembryonic Antigen: Difference between revisions

From Taranaki Lab Manual
Tests:Carcinoembryonic Antigen
Jump to navigation Jump to search
No edit summary
updated
Line 31: Line 31:
|Specimen  
|Specimen  
|Serum
|Serum
Plasma
|-
|-
|Preferred
|Preferred
|6 mL <span style="background:#e30022"> Red-Top </span>
|<span style="background: #fbec5d">Yellow-Top</span> or <span style="background:#e30022"> Red-Top </span> tube
|-
|-
|Acceptable
|Acceptable
|6 mL<span style="background: #fbec5d"> Yellow-Top</span>  
|
|-
|-
|Unacceptable
|Unacceptable
|
|Plasma
|-
|-
|Specimen Transportation
|Specimen Transportation
Line 46: Line 45:
|-
|-
|Paediatric Requirements
|Paediatric Requirements
|Minimum 0.5 mL blood in 6 mL <span style="background:#e30022"> Red-Top </span>
|0.5 mL blood in <span style="background:#e30022"> Red-Top </span> tube
|-
|-
! colspan="2" |
! colspan="2" |
Line 53: Line 52:
|Sample  
|Sample  
|Serum
|Serum
Plasma
|-
|-
|Preferred Volume
|Preferred Volume
|
|0.5 mL
|-
|-
|Minimum Volume
|Minimum Volume
|100 uL 
|100 µL 
|-
|-
|Aliquot Transportation
|Aliquot Transportation
Line 68: Line 66:
|-
|-
|Reference Intervals
|Reference Intervals
|0.0 - 5.0 ug/L 
|0.0 - 5.0 µg/L 
|-
|-
|Test Method
|Test Method
|Abbott Alinity Ci using Abbott reagents
|Abbott Alinity CI analyser, CMIA method
|-
|-
|Advanced Notice
|Advanced Notice

Revision as of 13:39, 20 August 2025


Overview

Department Biochemistry
Test Code TCEA
Synonyms CEA 
Availability Monday - Friday

Contact the lab if urgent testing is required

Turnaround Time 2 hours – 3 days
Stability – Add test 24 hours 

Specimen Requirements

Specimen Serum
Preferred Yellow-Top or Red-Top tube
Acceptable
Unacceptable Plasma
Specimen Transportation
Paediatric Requirements 0.5 mL blood in Red-Top tube

Aliquot Requirements

Sample Serum
Preferred Volume 0.5 mL
Minimum Volume 100 µL 
Aliquot Transportation

Clinical Information

Reference Intervals 0.0 - 5.0 µg/L 
Test Method Abbott Alinity CI analyser, CMIA method. 
Advanced Notice Not required  
Patient Preparation Not required  

Comments

CEA is a marker for colorectal, gastrointestinal, lung and breast carcinomas. 

CEA levels are not an absolute test for evidence of malignancy and must be used in conjunction with the clinical evaluation of the patient and other diagnostic evidence.

Healthy non-smokers have CEA levels less than 3.0 µg/mL, while 6% of otherwise healthy smokers have CEA levels up to 5.0 µg/mL. 

CEA is not suitable as a screening test for the primary diagnosis of tumours.

For the serial monitoring of tumours, tumour markers should be tested in the same laboratory.